RecruitingNot ApplicableNCT05053230

A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

Integrative Medicine for Patient-reported Outcomes, Values, and Experience (IMPROVE)

Sponsor

Memorial Sloan Kettering Cancer Center

Enrollment

480 participants

Start Date

Sep 20, 2021

Study Type

INTERVENTIONAL

Conditions

Ovarian Cancer Melanoma Head and Neck Cancer Gynecologic Cancer Thoracic Cancer Gynecologic Tumor Head and Neck Tumor Thoracic Tumor

Summary

The overarching long-term goal of the Integrative Medicine for Patient-reported Outcomes Values and Experience (IMPROVE) research program is to evaluate whether integrating a virtual mind-body programming, Integrative Medicine at Home (IM@Home), will improve patient perceived values, outcomes, and experiences as they undergo systemic cancer treatment such as chemotherapy, immunotherapy, radiotherapy, targeted agents, cytoreductive surgery.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study evaluates an integrative medicine program (combining conventional cancer care with approaches like acupuncture, massage, or meditation) delivered at home for people with cancer. The goal is to see whether this program reduces fatigue and improves quality of life during and after treatment. **You may be eligible if...** - You are 18 or older with a diagnosis of head and neck, lung, gynecologic, melanoma, or breast cancer — or have completed first-line treatment for gynecologic cancer - You are currently receiving cancer treatment or just finished it - You rate your fatigue as 4 or higher out of 10 in the past week - You are in reasonable health (Karnofsky score ≥60) with a life expectancy over 6 months - You are English-speaking **You may NOT be eligible if...** - Your cancer type is not listed above - You have very poor overall health or are not expected to survive more than 6 months - You do not speak English Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALIM@Home

Participants in the IM@Home group will receive a 12-week virtual, synchronous, mind-body and fitness program. The Classes will be conducted via Zoom video conferencing platform. Patients will choose from a variety of weekly classes, occurring one to four times per week. An Integrative Medicine Service (IMS) clinical therapist (e.g., licensed dance therapist, certified yoga instructor, nurse specialist/physical trainer) with specific expertise in the oncology setting will lead each session. Activities range from more movement-based (fitness, yoga, dance therapy, or tai chi) to meditative-based classes (meditation, guided meditation, or music therapy). All clinicians will provide an overview of the session, 25 to 40 minutes of content, and five minutes for feedback and discussion. Each class lasts 30 to 45 minutes with optional audio or video participant participation and group chat.

BEHAVIORALEnhanced usual care

Patients in the enhanced usual care will receive usual care. In addition, once enrolling into the trial, they will be given a handout to encourage them to visit the MSK's multimedia page on the Integrative Medicine website to access pre-recorded, on-demand meditation audio or video recordings for meditation, guided imagery, and relaxation.